Effect of Lipid-Lowering Treatment on Natural History of Heterozygous Familial Hypercholesterolemia in Past Three Decades

This publication has 14 references indexed in Scilit:

• Long-Term Safety and Efficacy of Triple Combination Ezetimibe/Simvastatin Plus Extended-Release Niacin in Patients With Hyperlipidemia
  The American Journal of Cardiology, 2010
• Extended-Release Niacin or Ezetimibe and Carotid Intima–Media Thickness
  New England Journal of Medicine, 2009
• Efficacy of statins in familial hypercholesterolaemia: a long term cohort study
  BMJ, 2008
• After ENHANCE: Is More LDL Cholesterol Lowering Even Better?
  Clinical Chemistry, 2008
• Autosomal recessive hypercholesterolaemia: normalization of plasma LDL cholesterol by ezetimibe in combination with statin treatment
  Journal of Internal Medicine, 2004
• A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia
  Atherosclerosis, 2003
• Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group.
  BMJ, 1991
• Cross sectional echocardiographic assessment of the aortic root and coronary ostial stenosis in familial hypercholesterolaemia.
  Heart, 1983
• Coronary Artery Disease in 116 Kindred with Familial Type II Hyperlipoproteinemia
  Circulation, 1974
• RISKS OF ISCHÆMIC HEART-DISEASE IN FAMILIAL HYPERLIPOPROTEINÆMIC STATES
  The Lancet, 1969